Controlled Substance Act

Showing 1 posts of 1 posts found.

fdaoutsideweb

FDA fast-tracks psilocybin treatment for major depressive disorder

November 25, 2019
Sales and Marketing Controlled Substance Act, FDA, breakthrough therapy, major depressive disorder, psilocybin

The FDA has granted a Breakthrough Therapy designation to the Usona Institute for its trial use of psilocybin in the …

The Gateway to Local Adoption Series

Latest content